causal
Mrna Commercialization Left Penn Research Elsewhere
Drew Weissman and Katalin Karikó's messenger RNA work, which was done at the University of Pennsylvania, was commercialized by companies in Boston and Germany rather than near its origin, which Marrazzo contrasts with Spark's decision to stay in Philadelphia.
causalpending
Speaker
JeffEvidence Quote
“that's the difference in the story between Spark and gene therapy and messenger RNA.”
Created: 11/11/2026, 6:53:25 PM
Your notes
Loading notes...